The Foundation is proud to announce that it will continue to work with the Canadian Institutes of Health Research and the European Union as part of the European Joint Programme on Rare Diseases 2020. The Foundation will fund $225,000 over a 3-year period for projects on Ataxia Charlevoix-Saguenay. The Canadian investment will be used to fund the participation of Canadian researchers in multinational research consortia in areas such as rare diseases.
The Ataxia Charlevoix-Saguenay Foundation participates in the European Joint Programme on Rare Diseases
by ARSACS | Jan 6, 2020 | News Archives